Given the importance of EGFR activation in NSCLC pathogenesis, we investigated the effect of sialidase NEU3 overexpression on EGFR downstream pathway activation and TKI targeted therapies sensitivity in a series of lung cancer cell lines. This evidence concerns the gene NEU3 and non-small cell lung carcinoma.